ResearcherGannan Medical UniversityActive in the last 2 years

Yuantong Tian

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5102408090. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer. Last author DOI 10.21037/cco-24-45 ↗
High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protoc… Last author DOI 10.21037/tcr-22-787 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Longxiang Yan · 1 shared paper, 2024 · strength 0.21
- Paper A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the … DOI 10.21037/cco-24-45 ↗
Alexis Zoa · 1 shared paper, 2022 · strength 0.16
- Paper High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta… DOI 10.21037/tcr-22-787 ↗
Jing Liang Yang · 1 shared paper, 2022 · strength 0.16
- Paper High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta… DOI 10.21037/tcr-22-787 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.